Long-term persistence of the immune response to antipneumococcal vaccines after Allo-SCT: 10-year follow-up of the EBMT-IDWP01 trial

[1]  A. Bousvaros,et al.  2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  A. Bousvaros,et al.  2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  D. Musher,et al.  Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults , 2011, Human vaccines.

[4]  H. Einsele,et al.  Relationship between IgG titers and opsonocytophagocytic activity of anti-pneumococcal antibodies after immunization with the 7-valent conjugate vaccine in allogeneic stem cell transplant , 2010, Bone Marrow Transplantation.

[5]  John Z. Liang,et al.  Safety and Immunogenicity of a 13-Valent Pneumococcal Conjugate Vaccine Compared to Those of a 7-Valent Pneumococcal Conjugate Vaccine Given as a Three-Dose Series with Routine Vaccines in Healthy Infants and Toddlers , 2010, Clinical and Vaccine Immunology.

[6]  H. Einsele,et al.  Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial. , 2010, Vaccine.

[7]  H. Einsele,et al.  Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  A. Razmpour,et al.  Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Deepali Kumar,et al.  A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  C. Dykewicz.  Vaccination of Hematopoietic Cell Transplant Recipients , 2007 .

[11]  K. O'Brien,et al.  Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue? , 2007, The Lancet. Infectious diseases.

[12]  C. Ohmann,et al.  Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation. , 2007, Blood.

[13]  R. Champlin,et al.  Streptococcus pneumoniae Infections in 47 Hematopoietic Stem Cell Transplantation Recipients: Clinical Characteristics of Infections and Vaccine-Breakthrough Infections, 1989-2005 , 2007, Medicine.

[14]  Deepali Kumar,et al.  Immunogenicity of Pneumococcal Vaccine in Renal Transplant Recipients—Three Year Follow‐up of a Randomized Trial , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  S. Trocciola,et al.  Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. , 2003, Blood.

[16]  P. Ljungman,et al.  Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey , 2002, British journal of haematology.

[17]  C. Frasch,et al.  Pneumococcal Type 22F Polysaccharide Absorption Improves the Specificity of a Pneumococcal-Polysaccharide Enzyme-Linked Immunosorbent Assay , 2001, Clinical Diagnostic Laboratory Immunology.

[18]  R. Dagan,et al.  A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers. , 2000, Vaccine.

[19]  C. Cordonnier,et al.  Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. , 1992, The Journal of infectious diseases.

[20]  J. Kersey,et al.  Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine. , 1986, The Journal of infectious diseases.